05:56:41 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-29 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-05-31 Kvartalsrapport 2024-Q1
2024-05-29 Ordinarie utdelning POLAR 0.00 SEK
2024-05-28 Årsstämma 2024
2024-02-23 Bokslutskommuniké 2023
2023-11-24 Kvartalsrapport 2023-Q3
2023-09-08 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-26 Kvartalsrapport 2023-Q1
2023-05-17 Årsstämma 2023
2023-05-05 Ordinarie utdelning POLAR 0.00 SEK
2023-03-13 Extra Bolagsstämma 2022
2023-02-24 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-27 Kvartalsrapport 2022-Q1
2022-05-06 Ordinarie utdelning POLAR 0.00 SEK
2022-05-05 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-06 Ordinarie utdelning POLAR 0.00 SEK
2021-05-05 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-11-27 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning POLAR 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-29 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2020-02-14 Extra Bolagsstämma 2020
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-05-07 Split POLAR 16:1
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-19 Årsstämma 2019
2019-02-04 Ordinarie utdelning POLAR 0.00 SEK
2019-02-01 Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamt inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2022-11-03 10:01:00

The med-tec company PolarCool AB (publ) continues to establish the PolarCap® in Swedish ice hockey, by signing a three year agreement with HockeyEttan club Nyköpings SK, for use of the PolarCap® System.

PolarCool develops and markets the product PolarCap, which alleviates the effects of concussion. The primary users of PolarCap include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, and handball, but also other sports with an increased risk of concussion.  PolarCool has a strong presence in SHL, yet the company has recently strengthened its presence among clubs within the lower levels of Swedish ice hockey, both in HockeyAllsvenskan and HockeyEttan.

HockeyEttan is the third division of Swedish ice hockey, and the league includes a total of 40 clubs playing across regional divisions. Nyköpings SK is now the fourth club in the league to sign an agreement with PolarCool this year. PolarCool's goal is to strengthen its presence in HockeyEttan and the agreement brings strategic value, even if the financial significance of individual agreements is limited.

Nyköpings SK's chairman Magnus Idebro comments;

-I am happy and proud that we in Nyköpings SK as a club choose to prioritize the safety of our players by providing the PolarCap System. We see the issue of our players' health and well-being as very important, and we hope for an extended collaboration within HockeyEttan and that more clubs will follow us to ensure players' safety.

PolarCool's CEO Erik Andersson comments;

-Offering the PolarCap System at all levels in sports is part of PolarCool's long-term strategy. I am glad that more and more clubs in HockeyEttan now thinks about the health and safety of their players and choose to provide PolarCap System. It also shows the broadens and potential of the market.